glp-1 and osteoarthritis GLP-1RA 'might be disease-modifying' in knee with type 2 diabetes Geniposide stimulates autophagy by activating

The Global Market Landscape for GLP-1 Medications GLP-1 therapies are rapidly expanding in Europe, the Asia-Pacific region, including India and China, driven by rising obesity and supportive healthcare initiatives

95% CI, 1.062.20) compared with the placebo

Lilly has struck similar deals with the Trump administration

Fiber slows digestion while protein amplifies satiety hormones

Additionally, GLP-1 activates related intracellular signaling pathways, promoting -cell regeneration, inhibiting -cell apoptosis, and improving -cell function, thereby lowering blood glucose levels, with its effects being glucose concentration-dependent (58, 59)

doi: 10.3390/ijms232314899